I think maybe the money's what's throwing you off here today.
Followers | 199 |
Posts | 17,203 |
Boards Moderated | 2 |
Alias Born | 02/17/2012 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OCGN nasdaq compliance next week
OCGN nasdaq compliance next week.
Gm ocuhub. HOLDING
OCGN
1.06 going
OCGN
Good afternoon, ocuhub
OCGN
Gm harry.
OCGN
Good afternoon, Ocuhub.
OCGN
.53 seller out
Gm ocuhub
Gm ocuhub
OCGN
OCGN .60 break
.60 pm
OCGN
Gm ocuhub
“Project NextGen will also support 10 to 15 phase 1 trials and 6 to 8 phase 2 trials at the NIAID, Beigel said. Companies will provide their vaccine candidates, while the NIAID will cover the costs of the trials.”
“Ocugen is the other company that has publicized its vaccine’s selection for NIAID trials. Its mucosal vaccine uses a chimp adenovirus to deliver the SARS-CoV-2 spike protein. Although the vaccine hasn’t yet been tested in humans in the US, it has completed phase 1, 2, and 3 trials in India, where, in the form of nose drops, it was authorized more than a year ago as a primary vaccine as well as a mix-and-match booster.”
https://jamanetwork.com/journals/jama/fullarticle/2812830
OCGN
OCGN Noblecon replay https://www.youtube.com/embed/6ik0xs3Z9Us
Gm ocuhub. Noble conference 2pm et
OCGN
Jan calls are interesting.
OCGN
.05? I don’t think so
OCGN
“Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates”
https://www.biorxiv.org/content/10.1101/2023.11.06.565765v1
OCGN
Shankar Musunuri was “Global Operations Team Leader for one of the most successful launches in vaccine history, Prevnar 13®.”
https://entrepreneurship.duke.edu/profile/shankar-musunuri-mba-06/
OCGN
gm ocuhub
OCGN
AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies
“Christopher J. Layton owns shares in Ocugene, a gene therapy company. Jason C. Steel has been a consultant for Ocugene and owns intellectual property in breast cancer gene therapy.”
https://link.springer.com/article/10.1007/s40259-023-00629-y
OCGN 8k for 180 day extension
https://www.sec.gov/ix?doc=/Archives/edgar/data/1372299/000162828023036087/ocgn-20231102.htm
Thu, 2nd Nov 2023 “Nasdaq Determines Ocugen, Inc. Eligible for an Additional 180-Day Period, or Until April 29, 2024, to Regain Compliance with the Minimum Bid Price Requirement”
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ocgn/ocugen/event/1860803306?utm_source=braze&utm_medium=email&utm_campaign=Critical+Updates&utm_content=Email
Thanks, urban!
Haha. Quite the choice for a username. Welcome to ihub, fellow long.
OCGN
OCGN Q3 conference call Nov 9. https://ir.ocugen.com/news-releases/news-release-details/ocugen-host-conference-call-thursday-november-9-830-am-et